Quote
Email Us
Gene Therapy

Gene Therapy

Tsingke Biotech provides an integrated manufacturing platform for gene therapy research and development, covering nucleic acid synthesis, viral vector production, and plasmid manufacturing. With in-house reagent supply and self-developed synthesis instruments, we deliver high-quality gene therapy components tailored for preclinical and research needs. Our capabilities span mRNA, saRNA, viral vector packaging, and plasmid production, ensuring seamless scale-up from laboratory studies to larger-scale research supply.

Advantages of Tsingke Gene Therapy

End-to-End Capability

From nucleic acid synthesis to GMP-ready therapeutic components.


Scalable Manufacturing

Research, pilot, and commercial-scale production under unified SOPs.


Quality Assurance

Dual verification for sequence integrity (Sanger + NGS where applicable) and comprehensive analytical testing.


Regulatory Compliance

Facilities and processes aligned with FDA, EMA, and NMPA standards for gene therapy manufacturing.


In-House Integration

Raw materials, instruments, and production capacity under complete supply chain control.

Contact Us
Explore the power of the Gene Factory and discover how Tsingke's integrated platform accelerates your R&D and product development.
Tsingke Updates
pop_close
pop_main
Subscribe to Our Newsletter

Stay updated with the latest industry news and expert insights. 

Subscribe now to receive:
        ● Industry updates
        ● Exclusive expert insights and analysis
Enter your email to stay ahead!

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept